Low Dose Infliximab for Prevention of Postoperative Recurrence of Crohn's Disease: Long Term Follow-Up and Impact of Infliximab Trough Levels and Antibodies to Infliximab.

Low Dose Infliximab for Prevention of Postoperative Recurrence of Crohn's Disease: Long Term Follow-Up and Impact of Infliximab Trough Levels and Antibodies to Infliximab.

<h4>Objective</h4>In patients with postoperative recurrence of Crohn's disease endoscopic and clinical remission can be maintained for up to 1 year with low infliximab doses (3 mg/Kg). However, in theory low-dose infliximab treated patients could develop subtherapeutic trough levels...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy: Dario Sorrentino, Marco Marino, Themistocles Dassopoulos, Dimitra Zarifi, Tiziana Del Bianco
Format: Artykuł
Język:English
Wydane: Public Library of Science (PLoS) 2015-01-01
Seria:PLoS ONE
Dostęp online:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0144900&type=printable

Internet

https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0144900&type=printable

Podobne zapisy